{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Foral-serds-for-hr-her2-neg-esr1m-mbc-vW87_xp1","width":444,"version":"1.0","type":"rich","title":"Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/4f87ec6c-751b-41ca-b86c-b9ac65eefc79/100135-pod-oral-serds-her-her2neg-esr1m-mbc.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/b94c83bd-5777-4f87-a227-fdf923f82686\" height=\"200\" width=\"100%\" title=\"Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Audio podcast with key highlights on current and emerging data for the use of oral SERDS in patients with HR+/HER2- ESR1-mutated advanced breast cancer. Listen to experts put new trial results into context and cover practical perspectives and takeaway points for your everyday practice."}